Pancreatic metastasis from thymic carcinoma diagnosed by endoscopic ultrasound-guided tissue acquisition: a case report influencing therapeutic strategy.
文献摘要
Pancreatic metastasis from thymic carcinoma is exceedingly rare and difficult to distinguish from primary pancreatic neoplasms based on imaging alone. We report a case of pancreatic and hepatic metastases from thymic carcinoma diagnosed by endoscopic ultrasound-guided tissue acquisition (EUS-TA), which directly influenced therapeutic management. A 74-year-old woman with a history of resected thymic carcinoma and hepatic metastasectomy presented with newly detected pancreatic and hepatic masses. Contrast-enhanced computed tomography and magnetic resonance imaging demonstrated a hypoenhancing pancreatic lesion with heterogeneous enhancement. Although the findings were nonspecific, they were atypical for conventional pancreatic ductal adenocarcinoma because the main pancreatic duct remained patent without upstream dilatation or pancreatic atrophy. EUS-TA using a 22-gauge Franseen needle provided sufficient tissue for histopathological and immunohistochemical evaluation. The pancreatic lesion showed morphological and immunohistochemical concordance with both the previously resected primary thymic carcinoma and hepatic metastasis, confirming metastatic disease. Histological diagnosis established systemic recurrence, avoided unnecessary pancreatic resection, and led to stereotactic body radiation therapy followed by systemic chemotherapy, resulting in tumor regression. This case highlights the pivotal role of EUS-TA in establishing an accurate diagnosis and guiding appropriate therapeutic management.